Canada Viscosupplementation Market is driven by Increasing Cases of Osteoarthritis
Viscosupplementation is a process of supplementing knee osteoarthritis patients with hyaluronic acid or hylan injections into the knee joint. It involves injecting highly purified and more dense hyaluronic acid preparations into the knee joint, where it attempts to improve the quality and quantity of synovial fluid. The main advantages of viscosupplementation include reduced pain, improved joint mobility and functionality, reduced stiffness, delayed need for knee replacement surgery, and relative safety as compared to other treatment options. Viscosupplementation has become a preferred treatment choice for symptomatic relief in patients with mild to moderate osteoarthritis who have not responded to conservative treatments like physical therapy and analgesics.
The Canada Viscosupplementation Market is estimated to be valued at USD 150.8 Mn in 2024 and is expected to reach USD 255.7 Mn by 2031, growing at a compound annual growth rate (CAGR) of 7.60% from 2024 to 2031.
The Canada Viscosupplementation Market is increasing primarily due to the rising prevalence of osteoarthritis in the country. According to Arthritis Alliance of Canada, over 6 million Canadians were estimated to be affected by osteoarthritis in 2020. Moreover, aging population, sedentary lifestyle, and growing obesity are some of the key factors contributing to osteoarthritis burden
Get More Insights On - Canada Viscosupplementation Market
Get this Report in Japanese Language: カナダの粘度サプリメント市場
Get this Report in Korean Language: 캐나다 점도 보충 시장
English
Arabic
Français
Español
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian